Mercer University College of Pharmacy faculty member Martin D’Souza, Ph.D., recently began research into designing a microparticle vaccine for COVID-19.
Dr. D’Souza has previously used patented nanotechnology to design and deliver nanovaccines for infectious diseases and cancer. His approach involves using tiny “bead-like” nanoparticles and microparticles to deliver drugs and vaccines.
“The advantage of putting a vaccine in a microparticle is that it looks even more foreign to the body,” said Dr. D’Souza. “Therefore, the body creates an even stronger immune response.”